Correction to: An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis

Authors

• Antonio M. Jimenez Jimenez, Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA. amjimenez@med.miami.edu.
• Marcos De Lima, Department of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.
• Krishna V. Komanduri, Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA.
• Trent P. Wang, Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA.
• Mei-Jie Zhang, (CIBMTR)® Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.Follow
• Karen Chen, (CIBMTR)® Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
• Hisham Abdel-Azim, Division of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
• Muhammad Bilal Abid, Divisions of Hematology/Oncology & Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
• Mahmoud Aljurf, Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
• Hassan Alkhateeb, Mayo Clinic Rochester, Rochester, MN, USA.
• Amer Assal, Columbia University Irving Medical Center, Department of Medicine, Bone Marrow Transplant and Cell Therapy Program, New York, NY, USA.Follow
• Ulrike Bacher, Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
• Frédéric Baron, CHU and University of Liege, Liege, Belgium.
• Minoo Battiwalla, Sarah Cannon Blood Cancer Network, Nashville, TN, USA.
• Amer Beitinjaneh, Division of Transplantation and Cellular Therapy, University of Miami Miller School of Medicine, Miami, FL, USA.Follow
• Nelli Bejanyan, Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, FL, USA.Follow
• Vijaya Raj Bhatt, The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.Follow
• Michael Byrne, Vanderbilt University Medical Center, Nashville, TN, USA.
• Jean-Yves Cahn, Department of Hematology, CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble, France.Follow
• Mitchell Cairo, Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, New York Medical College, Valhalla, NY, USA.Follow
• Paul Castillo, UF Health Shands Children's Hospital, Gainesville, FL, USA.Follow
• Edward Copelan, Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
• Zachariah DeFilipp, Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA, USA.Follow
• Miguel Angel Perez, Department of Hematology/Oncology, Hospital Infantil Universitario Niño Jesus, Madrid, Spain.
• Mahmoud Elsawy, Division of Hematology, Department of Medicine, Dalhousie University, Halifax, NS, Canada.
• Robert Peter Gale, Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK.Follow
• Biju George, Christian Medical College, Vellore, India.
• Michael R. Grunwald, Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
• Gerhard C. Hildebrandt, Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
• William J. Hogan, Division of Hematology/BMT, Mayo Clinic, Rochester, MN, USA.
• Christopher G. Kanakry, Experimental Transplantation and Immunotherapy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.Follow
• Ankit Kansagra, UT Southwestern Medical Center, Blood and Marrow Transplant Program, Dallas, TX, USA.Follow
• Mohamed A. Kharfan-Dabaja, Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA.Follow

Publication Title

Bone marrow transplantation

Recommended Citation

Jimenez Jimenez, Antonio M.; De Lima, Marcos; Komanduri, Krishna V.; Wang, Trent P.; Zhang, Mei-Jie; Chen, Karen; Abdel-Azim, Hisham; Abid, Muhammad Bilal; Aljurf, Mahmoud; Alkhateeb, Hassan; Assal, Amer; Bacher, Ulrike; Baron, Frédéric; Battiwalla, Minoo; Beitinjaneh, Amer; Bejanyan, Nelli; Bhatt, Vijaya Raj; Byrne, Michael; Cahn, Jean-Yves; Cairo, Mitchell; Castillo, Paul; Copelan, Edward; DeFilipp, Zachariah; Perez, Miguel Angel; Elsawy, Mahmoud; Gale, Robert Peter; George, Biju; Grunwald, Michael R.; Hildebrandt, Gerhard C.; Hogan, William J.; Kanakry, Christopher G.; Kansagra, Ankit; and Kharfan-Dabaja, Mohamed A., "Correction to: An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis" (2022). Loewenberg College of Nursing Faculty Publications. 37.
https://digitalcommons.memphis.edu/lcon-facpubs/37